GLPwatch

Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment.

Front Endocrinol (Lausanne) · 2023

Last updated 2026-05-28

In a study of elderly rats fed a high-fat, high-sucrose diet, long-term treatment with metformin or liraglutide did not prevent prediabetes or diabetes. The drugs had different effects by sex: liraglutide improved liver and muscle health in males but increased insulin resistance in females.

AI summary of the abstract below.

JournalFront Endocrinol (Lausanne), 2023
Citations3
Relative citation ratio0.46
NIH percentile27
Molecules liraglutide
Conditions studied Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Mash

Abstract

AIM/INTRODUCTION: The study aimed to determine the effectiveness of early antidiabetic therapy in reversing metabolic changes caused by high-fat and high-sucrose diet (HFHSD) in both sexes. METHODS: Elderly Sprague-Dawley rats, 45 weeks old, were randomized into four groups: a control group fed on the standard diet (STD), one group fed the HFHSD, and two groups fed the HFHSD along with long-term treatment of either metformin (HFHSD+M) or liraglutide (HFHSD+L). Antidiabetic treatment started 5 weeks after the introduction of the diet and lasted 13 weeks until the animals were 64 weeks old. RESULTS: Unexpectedly, HFHSD-fed animals did not gain weight but underwent significant metabolic changes. Both antidiabetic treatments produced sex-specific effects, but neither prevented the onset of prediabetes nor diabetes. CONCLUSION: Liraglutide vested benefits to liver and skeletal muscle tissue in males but induced signs of insulin resistance in females.

Verbatim abstract via PubMed 37929025 ↗

Related research